Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Health Care Reform and Business Development: 10 Reasons it Matters

Oct 01 2009

• By Michael McCaughan

Related Content

MedPAC On Steroids: The Implications of a New Medicare Advisory Council

Jul 01 2009

Cost Effectiveness in the US? Round One Goes Against Pharma

Apr 01 2009

Dollars for Donuts: Inside the Key Elements of PhRMA's Health Reform Deal

Jun 01 2009

Limiting Cost-sharing on Drugs: A Big PhRMA Objective from Health Reform

Aug 01 2009

Mind Your Bs and Ds

Jun 01 2006

Living in a Bipolar World: Implications of the EPO Safety Debate (Part 1)

Jul 01 2007

Big Pharma May Be Big Player in Follow-On Biologics Market

Apr 01 2008

A Cold Shower For Viagra: How Congress Can Chill A Market

Dec 01 2005

Pfizer/Wyeth: Industrializing Pharma?

Feb 01 2009

Additional Topics

Business Strategies Regulation Reimbursement BioPharmaceutical

More from Market Access

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window